Liver fibrosis is a dynamic wound-healing response characterized by the agglutination of the extracellular matrix(ECM).Si-Wu-Tang(SWT),a traditional Chinese medicine(TCM)formula,is known for treating gynecological dis...Liver fibrosis is a dynamic wound-healing response characterized by the agglutination of the extracellular matrix(ECM).Si-Wu-Tang(SWT),a traditional Chinese medicine(TCM)formula,is known for treating gynecological diseases and liver fibrosis.Our previous studies demonstrated that long non-coding RNA H19(H19)was markedly upregulated in fibrotic livers while its deficiency markedly reversed fibrogenesis.However,the mechanisms by which SWT influences H19 remain unclear.Thus,we established a bile duct ligation(BDL)-induced liver fibrosis model to evaluate the hepatoprotective effects of SWT on various cells in the liver.Our results showed that SWT markedly improved ECM deposition and bile duct reactions in the liver.Notably,SWT relieved liver fibrosis by regulating the transcription of genes involved in the cytoskeleton remodeling,primarily in hepatic stellate cells(HSCs),and influencing cytoskeleton-related angiogenesis and hepatocellular injury.This modulation collectively led to reduced ECM deposition.Through extensive bioinformatics analyses,we determined that H19 acted as a miRNA sponge and mainly inhibited miR-200,miR-211,and let7b,thereby regulating the above cellular regulatory pathways.Meanwhile,SWT reversed H19-related miRNAs and signaling pathways,diminishing ECM deposition and liver fibrosis.However,these protective effects of SWT were diminished with the overexpression of H19 in vivo.In conclusion,our study elucidates the underlying mechanisms of SWT from the perspective of H19-related signal networks and proposes a potential SWT-based therapeutic strategy for the treatment of liver fibrosis.展开更多
目的:观察活血化瘀法对髋部骨折患者围手术期D-二聚体的影响,探讨活血化瘀法对髋部骨折并发下肢深静脉栓塞的防治作用。方法:选我院治疗的髋部骨折患者46例,随机分为两组,每组各23例。治疗组术前1天、术后1周连续静滴0.9%NS250 m L+复...目的:观察活血化瘀法对髋部骨折患者围手术期D-二聚体的影响,探讨活血化瘀法对髋部骨折并发下肢深静脉栓塞的防治作用。方法:选我院治疗的髋部骨折患者46例,随机分为两组,每组各23例。治疗组术前1天、术后1周连续静滴0.9%NS250 m L+复方丹参注射液20 m L,每天1次。术后第1天开始服用桃红四物汤,每日1剂,连续服用1周;对照组术前1天、术后连续1周腹壁皮下注射低分子肝素(速碧林)0.4 m L,每天1次。两组均于术前1天、术后1、3、7天,清晨空腹抽血测定静脉血D-二聚体含量。结果:术前1天、术后1天、术后3天2组D-二聚体含量比较,差异无统计学意义(P>0.05),术后7天2组D-二聚体差异有统计学意义(P<0.05)。结论:活血化瘀法对髋部骨折患者围手术期血浆D-二聚体含量有降低作用,可有效降低髋部骨折术后下肢深静脉栓塞形成的风险,是一种安全、可行和有效的治疗方案。展开更多
基金This work was supported by the National Natural Science Foundation of China(No.82004045)the National High-Level Talents Special Support Program,the Fundamental Research Funds for the Central Universities(No.2023-JYB-XJSJJ009)+1 种基金the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(No.ZYYCXTD-C-202006)the Young Talents Promotion Project of China Association of Traditional Chinese Medicine(No.2020-QNRC2-01).
文摘Liver fibrosis is a dynamic wound-healing response characterized by the agglutination of the extracellular matrix(ECM).Si-Wu-Tang(SWT),a traditional Chinese medicine(TCM)formula,is known for treating gynecological diseases and liver fibrosis.Our previous studies demonstrated that long non-coding RNA H19(H19)was markedly upregulated in fibrotic livers while its deficiency markedly reversed fibrogenesis.However,the mechanisms by which SWT influences H19 remain unclear.Thus,we established a bile duct ligation(BDL)-induced liver fibrosis model to evaluate the hepatoprotective effects of SWT on various cells in the liver.Our results showed that SWT markedly improved ECM deposition and bile duct reactions in the liver.Notably,SWT relieved liver fibrosis by regulating the transcription of genes involved in the cytoskeleton remodeling,primarily in hepatic stellate cells(HSCs),and influencing cytoskeleton-related angiogenesis and hepatocellular injury.This modulation collectively led to reduced ECM deposition.Through extensive bioinformatics analyses,we determined that H19 acted as a miRNA sponge and mainly inhibited miR-200,miR-211,and let7b,thereby regulating the above cellular regulatory pathways.Meanwhile,SWT reversed H19-related miRNAs and signaling pathways,diminishing ECM deposition and liver fibrosis.However,these protective effects of SWT were diminished with the overexpression of H19 in vivo.In conclusion,our study elucidates the underlying mechanisms of SWT from the perspective of H19-related signal networks and proposes a potential SWT-based therapeutic strategy for the treatment of liver fibrosis.
文摘目的:观察活血化瘀法对髋部骨折患者围手术期D-二聚体的影响,探讨活血化瘀法对髋部骨折并发下肢深静脉栓塞的防治作用。方法:选我院治疗的髋部骨折患者46例,随机分为两组,每组各23例。治疗组术前1天、术后1周连续静滴0.9%NS250 m L+复方丹参注射液20 m L,每天1次。术后第1天开始服用桃红四物汤,每日1剂,连续服用1周;对照组术前1天、术后连续1周腹壁皮下注射低分子肝素(速碧林)0.4 m L,每天1次。两组均于术前1天、术后1、3、7天,清晨空腹抽血测定静脉血D-二聚体含量。结果:术前1天、术后1天、术后3天2组D-二聚体含量比较,差异无统计学意义(P>0.05),术后7天2组D-二聚体差异有统计学意义(P<0.05)。结论:活血化瘀法对髋部骨折患者围手术期血浆D-二聚体含量有降低作用,可有效降低髋部骨折术后下肢深静脉栓塞形成的风险,是一种安全、可行和有效的治疗方案。
